NATR
NATURES SUNSHINE PRODUCTS INC
Key Financials
Net Income
$19.5M
↑ 153.7%
Revenue
$480.1M
↑ 5.7%
EPS (Diluted)
$1.06
↑ 165.0%
Total Assets
$261.1M
↑ 8.4%
Shareholders' Equity
$105.3M
↓ 9.0%
Cash & Equivalents
$93.9M
↑ 10.9%
Total Liabilities
$99.6M
↑ 24.7%
Dividends/Share
$0.00
↓ 100.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 9/15/2026 | View on SEC |
| 3 | 9/14/2026 | View on SEC |
| 4 | 9/3/2026 | View on SEC |
| 4 | 8/19/2026 | View on SEC |
| 4 | 8/10/2026 | View on SEC |
| SCHEDULE 13G/A | 8/10/2026 | View on SEC |
| 10-Q | 8/6/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| 4 | 6/29/2026 | View on SEC |
| 4 | 6/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NATR |
| Company Name | NATURES SUNSHINE PRODUCTS INC |
| CIK | 275053 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | UT |
| Phone | (801) 341-7900 |